Chat
Hypoglycemia Panel, Sulfonylureas Qualitative, Serum or Plasma
Copy Utility
Preferred test for evaluating if etiology of hypoglycemia is sulfonylurea ingestion.
Qualitative Liquid Chromatography-Tandem Mass Spectrometry
Sun, Tue, Thu
1-6 days
Plain red, gray (NaF/K Oxalate), green (Na Heparin), lavender (EDTA), or pink (K2EDTA).
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.4 mL)
Frozen. Also acceptable: Refrigerated.
Separator tubes.
Ambient: 48 hours; Refrigerated: 11 days; Frozen: 3 months
| Available Separately | Drug | Cutoff Concentration |
|---|---|---|
| No | Glyburide | 5 ng/mL |
| No | Glimepiride | 5 ng/mL |
| No | Glipizide | 5 ng/mL |
| No | Repaglinide | 5 ng/mL |
| No | Nateglinide | 5 ng/mL |
| No | Acetohexamide | 100 ng/mL |
| No | Chlorpropamide | 100 ng/mL |
| No | Tolazamide | 100 ng/mL |
| No | Tolbutamide | 100 ng/mL |
This assay is used to evaluate hypoglycemia that may be caused from the ingestion of sulfonylurea drugs. Hypoglycemic drugs are detected (present) in this assay if the drug concentration is greater than the limit of detection (cut-off). The presence of hypoglycemic drug(s) indicates a recent ingestion.
Compliance Statement B: For laboratory developed tests not using a RUO kit, and for FDA approved, cleared or 510(k) exempt assays with alterations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
Hotline History
80377 (Alt code: G0480)
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2010293 | Tolbutamide, Serum/Plasma | 21567-3 |
| 2010294 | Tolazamide, Serum/Plasma | 21566-5 |
| 2010295 | Repaglinide, Serum/Plasma | 48328-9 |
| 2010296 | Nateglinide, Serum/Plasma | 49487-2 |
| 2010297 | Glyburide, Serum/Plasma | 48327-1 |
| 2010298 | Glipizide, Serum/Plasma | 48326-3 |
| 2010299 | Glimepiride, Serum/Plasma | 48325-5 |
| 2010300 | Chlorpropamide, Serum/Plasma | 48329-7 |
| 2010301 | Acetohexamide, Serum/Plasma | 43626-1 |
- Amaryl (Glimepiride)
- Diabinese (Chlorpropamide)
- Diabinese{R} (Sulfonylurea Hypoglycemics Panel (Qualitative), Serum or Plasma)
- Dymelor (Acetohexamide)
- Glucotrol (Glipizide)
- Meglitinides
- Micronase (Glyburide)
- Orinase (Tolbutamide)
- Prandin (Regaglinide)
- Starlix (Nateglinide)
- Tolinase (Tolazamide)
